Rankings
▼
Calendar
LAB
Standard BioTools Inc.
$374M
Q3 2016 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$22M
Gross Profit
$12M
53.6% margin
Operating Income
-$18M
-83.3% margin
Net Income
-$20M
-89.2% margin
EPS (Diluted)
$-0.68
QoQ Revenue Growth
-21.2%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$15M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$320M
Total Liabilities
$252M
Stockholders' Equity
$68M
Cash & Equivalents
$32M
Geographic Segments
UNITED STATES
$13M
56%
Europe
$5M
23%
Asia Pacific
$4M
16%
Other Geographical Countries
$854,000
4%
← FY 2016
All Quarters
Q4 2016 →
LAB Q3 2016 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena
